Rational topical treatment of uncomplicated rhinosinusitis as a basis for successful recovery

Author:

Ovchinnikov A. Yu.1ORCID,Miroshnichenko N. A.1ORCID,Savranskaya K. V.1ORCID,Nikolaeva Yu. O.1ORCID

Affiliation:

1. Yevdokimov Moscow State University of Medicine and Dentistry

Abstract

The article is devoted to the treatment of one of the most common diseases - the treatment of rhinosinusitis. According to statistics only 2% of the sinusitis in population are bacterial. At the same time administration of systemic antibiotic therapy reaches 95.5%. The problem of rational prescription of antibacterial drugs, including management of the rhinosinusitis, is very acute, especially considering the constant increase in the number of antibiotic-resistant microorganisms. Currently, the level of patients with prolonged post-viral rhinosinusitis after COVID-19 has increased. Most have a history of one or more courses of systemic antibiotics and, often, without indications. In article are listed indications for systemic and local antibacterial therapy in adults and children, based on national and European clinical guidelines. The data on complications during the use of systemic antibacterial drugs are presented. Authors give information about the advantages of the local use of antibiotics: the absence of general toxic complications, the creation of an optimal concentration directly in the focus of inflammation. The advantages of combining solutions of neomycin and polymyxin B for topical use, such as a pronounced bactericidal effect against gram-positive and gram-negative bacteria (Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Haemophilus influenzae, Pseudomonas aeruginosa), causing the development of infectious processes in the upper respiratory tract, are separately noted. The author describes his own experience of using the original nasal spray Polydex with phenylephrine, containing a fixed combination of neomycin, polymyxin B, dexamethasone sodium metasulfobenzoate and phenylephrine, in the treatment of patients with post-viral rhinosinusitis. As a result of the collection of literature data, as well as based on their own experience, the authors concluded that the use of this nasal spray in outpatient practice will significantly improve the effectiveness of treatment and reduce the frequency of prescribing systemic antibiotics.

Publisher

Remedium, Ltd.

Subject

General Medicine

Reference28 articles.

1. Fokkens W., Desrosiers M., Harvey R., Hopkins C., Mullol J., Philpott C. et al. EPOS2020: Development Strategy and Goals for the Latest European Position Paper on Rhinosinusitis. Rhinology. 2019;57(3):162– 168. doi: 10.4193/Rhin17.253.

2. Wald E.R., Guerra N., Byers C. Upper Respiratory Tract Infections in Young Children: Duration of and Frequency of Complications. Pediatrics. 1991;87(2):129–133.

3. Ryazantsev S.V. The Principles of Etiopathogenetic Treatment of Acute Sinusitis. Meditsinskiy sovet = Medical Council. 2014;(15):13– 17. (In Russ.) doi: 10.21518/2079-701X-2014-15-13-17.

4. Lopatin A.S. (ed.). Acute Rhinosinusitis: Clinical Guidelines. Moscow: Rossiyskoye obshchestvo rinologov; 2017. 36 p. (In Russ.) Available at: http://rhinology.ru/wp-content/uploads/2017/09/Острыйриносинусит-21.09.pdf.

5. Bogomilskiy M.R., Chistyakova V.R. Pediatric otorhinolaryngology. Moscow: GEOTAR-MED; 2002. 432 p. (In Russ.) Avaliable at: http://www.booksshare.net/books/med/bogomolskiy-mr/2002/files/detskayaotorinolaringooliya2002.pdf.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3